微创与开腹胰十二指肠切除术治疗良性、癌前病变和恶性疾病。
Minimally invasive versus open pancreatoduodenectomy in benign, premalignant, and malignant disease.
机构信息
Department of Medical Imaging, Radboud University Medical Center Nijmegen, Nijmegen, Netherlands.
Department of Surgery, Radboud University Medical Center, Nijmegen, Netherlands.
出版信息
Cochrane Database Syst Rev. 2024 Jul 26;7(7):CD014017. doi: 10.1002/14651858.CD014017.
Abstract
This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the benefits and harms of laparoscopic or robot-assisted pancreatoduodenectomy versus open pancreatoduodenectomy for people with benign, premalignant, and malignant disease.
摘要
这是一份 Cochrane 综述（干预措施）的方案。其目的如下：评估腹腔镜或机器人辅助胰十二指肠切除术与开腹胰十二指肠切除术治疗良性、癌前病变和恶性疾病患者的疗效和安全性。
相似文献
1
Minimally invasive versus open pancreatoduodenectomy in benign, premalignant, and malignant disease.微创与开腹胰十二指肠切除术治疗良性、癌前病变和恶性疾病。
Cochrane Database Syst Rev. 2024 Jul 26;7(7):CD014017. doi: 10.1002/14651858.CD014017.
2
Minimally invasive versus open pancreatoduodenectomy (LEOPARD-2): study protocol for a randomized controlled trial.微创与开放胰十二指肠切除术（LEOPARD-2）：一项随机对照试验的研究方案
Trials. 2018 Jan 3;19(1):1. doi: 10.1186/s13063-017-2423-4.
3
Development of Minimally Invasive Pancreatic Surgery: an Evidence-Based Systematic Review of Laparoscopic Versus Robotic Approaches.微创胰腺手术的发展：腹腔镜与机器人手术方法的循证系统评价
J Gastrointest Surg. 2016 Sep;20(9):1658-65. doi: 10.1007/s11605-016-3204-1. Epub 2016 Jul 13.
4
Robot-assisted versus laparoscopic pancreatoduodenectomy: a pan-European multicenter propensity-matched study.机器人辅助与腹腔镜胰十二指肠切除术：泛欧多中心倾向评分匹配研究。
Surgery. 2024 Jun;175(6):1587-1594. doi: 10.1016/j.surg.2024.02.015. Epub 2024 Apr 3.
5
Minimally invasive versus open pancreatoduodenectomy for pancreatic and peri-ampullary neoplasm (DIPLOMA-2): study protocol for an international multicenter patient-blinded randomized controlled trial.微创与开腹胰十二指肠切除术治疗胰腺和壶腹周围肿瘤的比较（DIPLOMA-2）：一项国际多中心、患者盲法、随机对照临床试验的研究方案。
Trials. 2023 Oct 12;24(1):665. doi: 10.1186/s13063-023-07657-7.
6
Robotic versus Open Pancreatoduodenectomy for Pancreatic and Periampullary Tumors (PORTAL): a study protocol for a multicenter phase III non-inferiority randomized controlled trial.机器人与开腹胰十二指肠切除术治疗胰腺和壶腹周围肿瘤（PORTAL）：一项多中心 III 期非劣效性随机对照临床试验研究方案。
Trials. 2021 Dec 27;22(1):954. doi: 10.1186/s13063-021-05939-6.
7
[Early outcomes of open, laparoscopic and robot-assisted pancreatoduodenectomy].[开放手术、腹腔镜手术及机器人辅助胰十二指肠切除术的早期疗效]
Khirurgiia (Mosk). 2018(9):24-30. doi: 10.17116/hirurgia2018090124.
8
Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2): a multicentre, patient-blinded, randomised controlled phase 2/3 trial.腹腔镜与开腹胰十二指肠切除术治疗胰腺或壶腹周围肿瘤（LEOPARD-2）：一项多中心、患者盲法、随机对照 2/3 期试验。
Lancet Gastroenterol Hepatol. 2019 Mar;4(3):199-207. doi: 10.1016/S2468-1253(19)30004-4. Epub 2019 Jan 24.
9
Perioperative and oncologic outcome of robot-assisted minimally invasive (hybrid laparoscopic and robotic) pancreatoduodenectomy: based on pancreatic fistula risk score and cancer/staging matched comparison with open pancreatoduodenectomy.机器人辅助微创（杂交腹腔镜和机器人）胰十二指肠切除术的围手术期和肿瘤学结果：基于胰瘘风险评分和癌症/分期匹配与开放胰十二指肠切除术的比较。
Surg Endosc. 2021 Apr;35(4):1675-1681. doi: 10.1007/s00464-020-07551-2. Epub 2020 Apr 10.
10
Learning curve of laparoscopic and robotic pancreas resections: a systematic review.腹腔镜和机器人胰腺切除术的学习曲线：系统评价。
Surgery. 2021 Jul;170(1):194-206. doi: 10.1016/j.surg.2020.11.046. Epub 2021 Feb 2.
引用本文的文献
1
Laparoscopic management of intraductal oncocytic papillary neoplasm of the pancreas: Two case reports and review of literature.腹腔镜治疗胰腺导管内嗜酸性乳头状肿瘤：两例报告并文献复习
World J Gastrointest Surg. 2025 Apr 27;17(4):105096. doi: 10.4240/wjgs.v17.i4.105096.
本文引用的文献
1
Cancer statistics, 2024.2024年癌症统计数据。
CA Cancer J Clin. 2024 Jan-Feb;74(1):12-49. doi: 10.3322/caac.21820. Epub 2024 Jan 17.
2
Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.胰腺癌：欧洲肿瘤内科学会临床实践指南之诊断、治疗及随访
Ann Oncol. 2023 Nov;34(11):987-1002. doi: 10.1016/j.annonc.2023.08.009. Epub 2023 Sep 9.
3
Neoadjuvant therapy or upfront surgery for resectable and borderline resectable pancreatic cancer: A meta-analysis of randomised controlled trials.可切除和交界可切除胰腺癌的新辅助治疗或 upfront 手术：随机对照试验的荟萃分析。
Eur J Cancer. 2022 Jan;160:140-149. doi: 10.1016/j.ejca.2021.10.023. Epub 2021 Nov 24.
4
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews.PRISMA 2020 声明：系统评价报告的更新指南。
PLoS Med. 2021 Mar 29;18(3):e1003583. doi: 10.1371/journal.pmed.1003583. eCollection 2021 Mar.
5
International consensus guidelines for surgery and the timing of intervention in chronic pancreatitis.国际慢性胰腺炎手术和干预时机共识指南。
Pancreatology. 2020 Mar;20(2):149-157. doi: 10.1016/j.pan.2019.12.005. Epub 2019 Dec 17.
6
RoB 2: a revised tool for assessing risk of bias in randomised trials.《随机对照试验偏倚风险评估工具2：修订版》
BMJ. 2019 Aug 28;366:l4898. doi: 10.1136/bmj.l4898.
7
Evaluation and Management of Neuroendocrine Tumors of the Pancreas.胰腺神经内分泌肿瘤的评估和管理。
Surg Clin North Am. 2019 Aug;99(4):793-814. doi: 10.1016/j.suc.2019.04.014. Epub 2019 May 27.
8
Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2): a multicentre, patient-blinded, randomised controlled phase 2/3 trial.腹腔镜与开腹胰十二指肠切除术治疗胰腺或壶腹周围肿瘤（LEOPARD-2）：一项多中心、患者盲法、随机对照 2/3 期试验。
Lancet Gastroenterol Hepatol. 2019 Mar;4(3):199-207. doi: 10.1016/S2468-1253(19)30004-4. Epub 2019 Jan 24.
9
European evidence-based guidelines on pancreatic cystic neoplasms.欧洲胰腺囊性肿瘤循证临床实践指南。
Gut. 2018 May;67(5):789-804. doi: 10.1136/gutjnl-2018-316027. Epub 2018 Mar 24.
10
Partial pancreatoduodenectomy versus duodenum-preserving pancreatic head resection in chronic pancreatitis: the multicentre, randomised, controlled, double-blind ChroPac trial.慢性胰腺炎行胰十二指肠切除术与保留十二指肠胰头切除术的对比：多中心、随机、对照、双盲 ChroPac 试验。
Lancet. 2017 Sep 9;390(10099):1027-1037. doi: 10.1016/S0140-6736(17)31960-8.
Zotero 插件